Maxcyte, Inc. SEC filings MXCT

Maxcyte, Inc. has 336 filings in SEC EDGAR's recent list, going back to Apr 14, 2004. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 25, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
10-K Annual report Mar 11, 2025 Dec 31, 2024
ARS Annual report to shareholders May 1, 2024 Dec 31, 2023
10-K Annual report Mar 12, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 29, 2022 Dec 31, 2021
10-K Annual report Mar 22, 2022 Dec 31, 2021

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
MXCT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Rockville, MD
SEC filer status
, Emerging growth company
SEC CIK
1287098
Former names
MAXCYTE INC (until Sep 18, 2008)

Other Services-Commercial Physical & Biological Research companies

All 17 Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.